FRRSF yields 33.06% · JNJ yields 2.13%● Live data
📍 FRRSF pulled ahead of the other in Year 1
Combined, FRRSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FRRSF + JNJ for your $10,000?
Foremost Lithium Resource & Technology Ltd., an exploration company, engages in the identification and development of mineral properties in Canada and the United States. It explores for lithium, silver, and gold properties. The company has 100% interests in the Zoro Lithium project that comprise three contiguous areas/claims with a total area of approximately 3,603 hectares located in Snow Lake, Manitoba; and the Winston property that includes 149 unpatented lode, the Ivanhoe and Emporio patented, and four unpatented mining claims located in Sierra County, New Mexico. It also holds an option agreement to acquire a 100% interest in the Jean Lake lithium-gold project that covers an area of 1002 hectares located to the north of Winnipeg, as well as 90% interests in the Hidden Lake project comprises five contiguous claims covering approximately 1,659.29 hectares located in the Northwest Territories. The company was formerly known as Far Resources Ltd. and changed its name to Foremost Lithium Resource & Technology Ltd. in January 4, 2022. Foremost Lithium Resource & Technology Ltd. was incorporated in 2005 and is headquartered in Vancouver, Canada.
Full FRRSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.